ArticleThe American journal of pathology2026
Dermal Microvascular Responses of Human Induced Pluripotent Stem Cell-Derived Skin Organoids to Inflammation and Injury.
Article in The American journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cutaneous dermal microvascular responses are critical to common inflammatory skin conditions and effective wound healing. However, few laboratory models effectively recreate the spatially intact microenvironment essential for genesis and function of the human dermal microcirculation. Recently, stem cell-derived skin organoids (SKOs) have been developed that possess many microanatomic and cellular features of native human skin, including hair-forming epidermis and an underlying dermal layer containing endothelial-lined channels. Here, temporal dynamics of human SKO vasculogenesis are profiled and organoid responses to inflammatory and traumatic stimuli are interrogated. SKOs generated from induced pluripotent stem cells expressing endothelial-specific green fluorescent protein develop vasculogenic foci by post-differentiation day 6 that evolved into extensive microvascular networks that persisted beyond 4 months in culture. Multiplex antibody arrays provided mechanistic insight into secreted effectors supporting early events in SKO vasculogenesis. Over time, SKO microvasculature became ensheathed by mural cells producing collagen IV-rich basement membranes, whereas endothelium retained signatures of proliferative activity/immaturity. Functionally, SKOs treated with proinflammatory cytokines expressed markers of endothelial and perivascular vascular activation, with concomitant release of endogenous inflammatory mediators. Finally, wounding of SKOs via sharp dissection provided the first demonstration of angiogenic healing responses that were further augmented by exogenous vascular endothelial growth factor. Overall, this advanced human culture system represents a highly relevant model for understanding biological responses by the dermal microvasculature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.